Composition for reducing inhibition of nucleic acid amplification

1. An aqueous composition for eliminating sample inhibition in an isothermal nucleic acid amplification reaction, said aqueous composition comprising:

an organic iron-chelating reagent;

ferric iron; and

a non-ionic surfactant at a concentration greater than or equal to 0.005% (mass/volume);

wherein the aqueous composition has a pH of about 8.45-8.85;

wherein the organic iron-chelating reagent has a first affinity constant greater than or equal to 10 4.2 with respect to ferric iron and a second affinity constant less than 10 3.8 with respect to magnesium, wherein the first affinity constant and the second affinity constant are determined in deionized water at pH 8.45 and 20° C.; and wherein the composition further comprises 2-hydroxypropane-1,2,3-tricarboxylate, wherein the organic iron-chelating reagent and the 2-hydroxypropane-1,2,3-tricarboxylate are distinct molecules.

2. The aqueous composition of claim 1 , wherein the organic iron-chelating reagent is selected from the group consisting of ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid; N,N,N′,N′-tetrakis(2-pyridylmethyl)ethane-1,2-diamine; 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; N-(2-Hydroxyethyl)ethylenediamine-N,N′,N′-triacetic acid; and salts thereof.

3. The aqueous composition of claim 1 , wherein the organic iron-chelating reagent comprises EGTA, wherein a molar ratio of ferric iron to the EGTA is about 0.04 to about 0.28.

4. The aqueous composition of claim 1 , wherein the non-ionic surfactant has a Hydrophilic-lipophilic balance of about 11 to about 16.

5. The aqueous composition of claim 1 , wherein the non-ionic surfactant is present at a concentration up to about 0.3% (mass/volume).

6. The aqueous composition of claim 1 , wherein the ferric iron is dissolved in the aqueous composition at a concentration of about 50 μM to about 350 μM.

7. The aqueous composition of claim 1 , further comprising polyvinylpyrrolidone.

8. The composition of claim 1 , further comprising a fluorosurfactant.

9. The composition of claim 1 , further comprising an indicator dye.

10. An isothermal nucleic acid amplification method, said method comprising:

a) contacting the composition of claim 1 with a target sample to form an aqueous mixture;

b) subjecting the aqueous mixture of step a) to a thermal lysis process; and

c) subsequent to step b), subjecting a portion of the aqueous mixture to an isothermal nucleic acid amplification process.

11. The method of claim 10 , wherein isothermal nucleic acid amplification process comprises loop-mediated isothermal amplification.

12. The method of claim 10 , wherein the composition further comprises a buffering agent, and an enhancer for facilitating a LAMP-BART reaction.

13. The method of claim 10 , wherein subjecting the mixture to thermal lysis comprises heating the mixture to about 100° C. for about 15 minutes, wherein the cooled lysate is added to a control LAMP-BART pellet for isothermal amplification.

14. An aqueous composition for eliminating sample inhibition in an isothermal nucleic acid amplification reaction, said aqueous composition comprising:

an organic iron-chelating reagent;

ferric iron; and

a non-ionic surfactant at a concentration greater than or equal to 0.005% (mass/volume);

wherein the aqueous composition has a pH of about 8.45-8.85;

wherein the organic iron-chelating reagent has a first affinity constant greater than or equal to 10 4.2 with respect to ferric iron and a second affinity constant less than 10 3.8 with respect to magnesium, wherein the first affinity constant and the second affinity constant are determined in deionized water at pH 8.45 and 20° C.; and wherein the composition further comprises a fluorosurfactant.

15. The aqueous composition of claim 14 , wherein the organic iron-chelating reagent is selected from the group consisting of ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid; N,N,N′,N′-tetrakis(2-pyridylmethyl)ethane-1,2-diamine; 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; N-(2-Hydroxyethyl)ethylenediamine-N,N′,N′-triacetic acid; and salts thereof.

16. The aqueous composition of claim 14 , wherein the organic iron-chelating reagent comprises EGTA, wherein a molar ratio of ferric iron to the EGTA is about 0.04 to about 0.28.

17. The aqueous composition of claim 14 , further comprising 2-hydroxypropane-1,2,3-tricarboxylate, wherein the organic iron-chelating reagent and the 2-hydroxypropane-1,2,3-tricarboxylate are distinct molecules.

18. The aqueous composition of claim 14 , wherein the non-ionic surfactant has a Hydrophilic-lipophilic balance of about 11 to about 16.

19. The aqueous composition of claim 14 , wherein the non-ionic surfactant is present at a concentration up to about 0.3% (mass/volume).

20. The aqueous composition of claim 14 , wherein the ferric iron is dissolved in the aqueous composition at a concentration of about 50 μM to about 350 μM.

21. The aqueous composition of claim 14 , further comprising polyvinylpyrrolidone.

22. The composition of claim 14 , further comprising an indicator dye.

23. An isothermal nucleic acid amplification method, said method comprising:

a) contacting the composition of claim 14 with a target sample to form an aqueous mixture;

b) subjecting the aqueous mixture of step a) to a thermal lysis process; and

c) subsequent to step b), subjecting a portion of the aqueous mixture to an isothermal nucleic acid amplification process.

24. The method of claim 23 , wherein isothermal nucleic acid amplification process comprises loop-mediated isothermal amplification.

25. The method of claim 23 , wherein the composition further comprises a buffering agent, and an enhancer for facilitating a LAMP-BART reaction.

26. The method of claim 23 , wherein subjecting the mixture to thermal lysis comprises heating the mixture to about 100° C. for about 15 minutes, wherein the cooled lysate is added to a control LAMP-BART pellet for isothermal amplification.